The pacemaker role of the suprachiasmatic nucleus in a mammalian circadian system was tested by neural transplantation by using a mutant strain of hamster that shows a short circadian period. Small neural grafts from the suprachiasmatic region restored circadian rhythms to arrhythmic animals whose own nucleus had been ablated. The restored rhythms always exhibited the period of the donor genotype regardless of the direction of the transplant or genotype of the host. The basic period of the overt circadian rhythm therefore is determined by cells of the suprachiasmatic region. All animals used in these experiments were raised in our colony, and only male animals were used as hosts. These were placed in running wheel cages for activity recording after reaching 8 weeks of age and were kept in constant dim light or constant dark for the duration of the experiment. After the period of the host rhythms had been established (7 to 21 days), animals were anesthetized and placed in a Kopf model 900 stereotaxic instrument for SCN ablation. Lesions were made by current in-
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The pacemaker role of the suprachiasmatic nucleus in a mammalian circadian system was tested by neural transplantation by using a mutant strain of hamster that shows a short circadian period. Small neural grafts from the suprachiasmatic region restored circadian rhythms to arrhythmic animals whose own nucleus had been ablated. The restored rhythms always exhibited the period of the donor genotype regardless of the direction of the transplant or genotype of the host. The basic period of the overt circadian rhythm therefore is determined by cells of the suprachiasmatic region. T 
HERE IS CONSIDERABLE EVIDENCE to suggest that the suprachiasmatic nucleus (SCN) of the hypothalamus is the site of circadian pacemaker cells that generate overt circadian rhythms in mammals. The evidence that supports this view is diverse. (i) The SCN is the target of direct and indirect retinal projections required for entrainment of circadian rhythms to environmental cycles (1, 2). (ii) The SCN exhibits strong circadian rhythms of glucose utilization in vivo (3). (iii) Ablation of the SCN or its surgical isolation within the brain eliminates overt behavioral rhythmicity (4-
) and rhythmic electrical activity in the brain (7). (iv) Tissue explants containing the SCN continue to express circadian rhythms in electrical activity (8, 9) and vasopressin release (10) in vitro. (v) Circadian rhythmicity can be restored to SCN-lesioned arrhythmic hosts by implantation of fetal brain tissue containing SCN cells (11) (12) (13) (14) .
Despite this evidence, however, the pacemaker role of the SCN circadian oscillator has not been confirmed. In addition, the role of the nucleus has come into question because methamphetamine given on a longterm basis to arrhythmic, SCN-lesioned rats M. R. Ralph will restore circadian rhythmicity (15) . Moreover, in the rat (16) and in lower vertebrates (17), structures outside the SCN are able to generate circadian rhythms.
Although in the aggregate the evidence is compelling, final proof that the SCN is the site of a central driving oscillator for mammalian circadian systems requires that characteristics of the overt rhythm such as phase and period be unambiguously attributable to the activity of SCN cells. The discovery of the T mutation in hamsters provided the opportunity to test directly the pacemaker role of the SCN by tissue transplantation. The mutation has the primary behavioral effect of reducing the period of the circadian rhythm from 24 hours to about 22 hours in heterozygotes and to about 20 hours in homozygotes (18) . If the SCN drives overt behavioral rhythmicity in hamsters, then the period of the rhythm that is restored by SCN transplantation should reflect the genotype of the donor tissue and not that of the lesioned host.
All animals used in these experiments were raised in our colony, and only male animals were used as hosts. These were placed in running wheel cages for activity recording after reaching 8 weeks of age and were kept in constant dim light or constant dark for the duration of the experiment. After the period of the host rhythms had been established ( In most cases, transplants were performed between 3 and 4 weeks after SCN ablation. When transplants involved hosts and donor tissue with the same genotype, the operation was performed at least 3 weeks after ablation so that there would be ample opportunity to identify rhythmicity that persisted in incompletely lesioned animals. In four cases, in which transplants involved donor and host of different genotype, the implantation was performed 1 week after SCN ablation to make a preliminary assessment of whether the timing of the two operations influenced the success rate of the transplantation procedure.
Fetal tissue was obtained on embryonic day 13. Circadian rhythmicity was restored unambiguously in about 80% of the arrhythmic hosts that received SCN implants. Only rhythmicity that was visible to naive observers of the raw activity data is presented in this report. Rhythmicity was not restored in animals that received cortical tissue implants (n = 4), although apparently healthy implants were found later during immunocytochemical analysis. Time series (fast Fourier) analysis was used to confirm the presence of rhythmicity restored by SCN transplantation and to confirm the absence of donor rhythmicity in the activity of control animals. This analysis indicated the presence of residual rhythmicity in some animals after SCN lesions. Because of the difference in period length between host and donor phenotype, this residual rhythmicity did not interfere with the interpretation of the rhythmicity restored by transplantation.
The period of restored rhythms always matched that predicted by the genotype of the donor tissue. Examples of rhythmicity restored by transplantation are shown in Fig. 1. When wild- , and a plug of donor tissue was found within the third ventricle. These plugs were always found in close apposition to the ependymal wall. VIP-positive perikarya and fibers were always identified within these implants, and in most cases cells and fibers formed a discrete "ball" (Fig. 3, A and B) reminiscent of the organization of VIP within the SCN. We could never clearly trace VIP fibers extending from the graft and crossing the host-graft border, although this was strongly suggested in some sections (Fig. 3C) . Vasopressin-positive perikarya that resemble the vasopressin immunoreactive perikarya within the SCN were also consistently found in the implant (Fig. 3,  E to G) . These perikarya were often difficult to identify because of their small size (long axis around 10 ,um) and weak immunostaining. In these cells, much of the soma was occupied by the nucleus (Fig. 3E) . Vasopressin immunoreactive perikarya were often associated with a fine plexus of varicose fibers showing weak vasopressin immunostaining. These SCN-like vasopressin perikarya and fibers contrast with vasopressin cells of the magnocellular system, which show large, strongly immunoreactive perikarya (long axis around 25 p,m) and fibers. Such cells were also identified within some of the implants (Fig. 3D ), suggesting that we had occasionally transplanted part of the magnocellular system. NPY-positive fibers were always found crossing the host-graft border (Fig. 3, H and I perikarya or fibers within the graft or evidence that NPY fibers were entering the graft from the host. In contrast to implants that contained the SCN, cortical implants never restored rhythmicity to the host. Cortical implants always contained a few NPY perikarya and many fibers. In cortical implants, NPY fibers were always seen to cross the host-graft border, and most crossing fibers seemed to originate from the host. Although most of our implants contained some portion of extra-SCN tissues (Fig. 3,  A and D) , the immunocytochemical analysis showed that grafts that restored rhythmicity always contained cells with SCN characteristics (VIP and vasopressin). Therefore, the period of the overt rhythm is determined by cells within, or very close to the SCN. This observation is in agreement with reports showing that the SCN is required for successful restoration of rhythmicity (11-14, 23).
In most of our locomotor data, rhythmicity was visually apparent within 6 to 7 days after transplantation. Although surprisingly short, this latency does not preclude the possibility that neural reconnections drive the behavior since dense neural outgrowth has been reported from other transplanted tissue with a similar time course (24). Immunocytochemical analysis indicates that neural connections have been made between graft and host brain; however, it was not possible to determine the source of fibers crossing the graft boundary.
The fact that the genotype of the host does not appear to affect significantly the expression of the transplanted rhythm is somewhat surprising, especially in view of evidence for the existence of oscillators outside the SCN in the mammalian brain (15, 16). We interpret the absence of a host contribution to the circadian period to mean that either the SCN is essentially autonomous in determining the primary characteristics of rhythmicity in hamsters or that the host brain fails to make the connections with the tissue graft that are required for the brain to influence this period. In either case, our results strengthen the view that the SCN occupies a position at the top of the circadian hierarchy in mammals.
